SIRT5

NAD-dependent protein deacylase sirtuin-5, mitochondrial · Q9NXA8 · SIRT5 on Sugi Atlas →

49,977 patent compounds predicted against SIRT5, 33,974 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL487145 SCHEMBL487145 0.56 6/20
Balsalazide Balsalazide (SCHEMBL118300) 1.00 5/20
Balsalazide Balsalazide (SCHEMBL138311) 1.00 5/20
Balsalazide Balsalazide (SCHEMBL134019) 0.97 5/20
Balsalazide Balsalazide (SCHEMBL133200) 0.95 5/20
Balsalazide Balsalazide (SCHEMBL30360) 0.67 5/20
Balsalazide Balsalazide (SCHEMBL30361) 0.65 5/20
SCHEMBL236067 SCHEMBL236067 0.51 5/20
SCHEMBL418900 SCHEMBL418900 0.51 5/20
SCHEMBL448179 SCHEMBL448179 0.51 5/20
SCHEMBL12126 SCHEMBL12126 0.45 5/20
SCHEMBL46214 SCHEMBL46214 0.46 4/20
Echinocystic Acid Echinocystic Acid (SCHEMBL42864) 1.00 3/20
Primulagenin Primulagenin (SCHEMBL179854) 0.69 3/20
Aleuritolic Acid Aleuritolic Acid (SCHEMBL438408) 0.59 3/20
SCHEMBL420802 SCHEMBL420802 0.55 3/20
SCHEMBL446710 SCHEMBL446710 0.55 3/20
SCHEMBL446711 SCHEMBL446711 0.55 3/20
SCHEMBL381990 SCHEMBL381990 0.52 3/20
SCHEMBL468736 SCHEMBL468736 0.47 3/20

Clinical trials — most relevant to SIRT5 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Cardiotoxicity in Breast Cancer Patients PHASE4RECRUITING
Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients PHASE3UNKNOWN
Sirtuin-NAD Activator in Alzheimer's Disease PHASE1/PHASE2ACTIVE_NOT_RECRUITING
Oral Nitrite for Older Heart Failure Patients PHASE2COMPLETED
Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction PHASE1/PHASE2RECRUITING
Nitrites, Skeletal Muscle Mitochondrial Bioenergetics, and Physical Activity in Old Age PHASE2COMPLETED
NADream: Effects of Nicotinamide Adenine Dinucleotide Supplementation on Sleep Quality in Healthy Individuals PHASE2RECRUITING
The Safety and Efficacy of an NAD+ Boosting Product Together With a Low Carbohydrate Diet in Adults With Mild Hypertension and Eligible for Normal-standard-of-care PHASE2COMPLETED
Clinical Trial of 2-HOBA in Pulmonary Arterial Hypertension PHASE2NOT_YET_RECRUITING
Phase 1a Single Ascending Dose Study of MIB-725 in Healthy Adults PHASE1RECRUITING
Tracing the Metabolic Flux of Orally Administered NAD+ Precursors PHASE1RECRUITING
Nicotinamide Riboside as an Enhancer of Exercise Therapy in Hypertensive Older Adults (The NEET Trial) PHASE1COMPLETED
Sirtuin1 in COVID19 Patients nanUNKNOWN
How Sirtuin Levels Change During Behçet Disease nanUNKNOWN
Project SIRT6 Activator nanRECRUITING
Impact of Nicotinamide Riboside (NR) on Kidney Function in Patients Undergoing Cardiac Surgery nanNOT_YET_RECRUITING
Sirtuin 3 and Sirtuin 7 in Systemic Sclerosis nanUNKNOWN
Influence of WNT4 VEZT FSHB and SIRT1 SNPs in Endometriosis: a Case Control Study of the Sardinian Population nanUNKNOWN
Inflammatory Axis and Sirtuins' in Overweight Pre-diabetics Patients nanCOMPLETED
Comparison of Cardiometabolic Markers in Individuals With Hypertriglyceridemia With Low and High Weight Loss Responses to an Energy-restricted Diet nanCOMPLETED
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes nanCOMPLETED
The PRE-OP ENERGY Trial nanUNKNOWN
The Effects of Resveratrol on Sirtuins and Apoptosis Biomarkers nanUNKNOWN
Short Interval Resveratrol Trial in Cardiovascular Surgery nanACTIVE_NOT_RECRUITING
Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression nanCOMPLETED
SWE to Detect Enthesitis in PsA: Relationship With SIRT2 Expression and Disease Activity nanNOT_YET_RECRUITING
The Safety and Efficacy Study of RiaGev in Healthy Adults nanUNKNOWN
Low Sirtuin-1 Levels Are Linked to Erythropoietin Resistance in Hemodialysis Patients. nanCOMPLETED
Expression of Longevity Genes in Response to Extended Fasting nanCOMPLETED
Inflammation in COPD and the Effect of Nicotinamide Riboside nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SIRT5 binder may also engage these)

ProteinNameSimilarity
Q5R6G3 1.000 Q5R6G3 →
F7EZ75 1.000 F7EZ75 →
Q3ZBQ0 1.000 Q3ZBQ0 →
E2RDZ6 1.000 E2RDZ6 →
F7DKV7 1.000 F7DKV7 →
Q68FX9 1.000 Q68FX9 →
Q6DHI5 0.999 Q6DHI5 →
Q5HZN8 0.997 Q5HZN8 →
Q68F47 0.997 Q68F47 →
E9GD30 0.996 E9GD30 →
E1BRE2 0.995 E1BRE2 →
Q5RBF1 0.991 Q5RBF1 →
Q2QMG2 0.988 Q2QMG2 →
Q83RR8 0.987 Q83RR8 →
Q94AQ6 0.987 Q94AQ6 →
C5G8R4 0.986 C5G8R4 →
Q8K2C6 0.986 Q8K2C6 →
Q42523 0.986 Q42523 →
P0C585 0.986 P0C585 →
P09842 0.985 P09842 →
Q5AW69 0.985 Q5AW69 →
A9UVV1 0.985 A9UVV1 →
Q7UFQ9 0.985 Q7UFQ9 →
Q57V41 0.985 Q57V41 →
A6R8Q8 0.985 A6R8Q8 →
Q8X8E0 0.985 Q8X8E0 →
Q9SS48 0.985 Q9SS48 →
Q9FE17 0.985 Q9FE17 →
P0A2F3 0.984 P0A2F3 →
Q5ZHX9 0.984 Q5ZHX9 →